Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Cassava 2, History, Domestication; Biotech Virus Resistance

Cassava 2, History, Domestication; Biotech Virus Resistance

FromTalking Biotech with Dr. Kevin Folta


Cassava 2, History, Domestication; Biotech Virus Resistance

FromTalking Biotech with Dr. Kevin Folta

ratings:
Length:
42 minutes
Released:
Oct 24, 2015
Format:
Podcast episode

Description

Biotech innovation in cassava is necessary to speeding genetic improvement of this food staple. Together with breeding efforts, the new resources derived define new crops that primarily serve the developing world.  Yet the Western world knows so little about cassava. This episode of Talking Biotech is part two of the series on cassava genetic improvement.  Dr. Barbara Schaal speaks about its genetic origins, migration and domestication.  Dr. Nigel Taylor describes the extensive work ongoing at the Danforth Center on cassava, and focuses on installation of virus resistance.# COLABRATalking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/# TALKING BIOTECHTwitter: https://twitter.com/talkingbiotechWebsite: https://www.colabra.app/podcasts/talking-biotech/Instagram: https://www.instagram.com/colabrahqThe Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
Released:
Oct 24, 2015
Format:
Podcast episode

Titles in the series (100)

Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering. Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050. Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.